Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy

Sponsor
Yonsei University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04141943
Collaborator
(none)
196
1
2
18.6
10.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the effect of providing information about radiotherapy using virtual reality and to see whether it would improve the productivity of medical staff, improve patient experience and satisfaction, and reduce patient's anxiety prior to radiotherapy.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual reality
N/A

Detailed Description

All patients enrolled in this study will receive the same routine explanation all radiotherapy patients receive currently. However, prior to the routine explanation, additional detailed information regarding radiotherapy (from simulation to treatment) will be given in two different ways.

VR arm: The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.

Printed document arm: The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.

Patients will answer the questionnaire related to the anxiety scale related to radiotherapy and measure the vital signs such as blood pressure, pulse rate, and the respiratory rate. Also, patients will answer the questions about radiotherapy to assess the understanding of radiotherapy and questionnaire on hospital satisfaction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
196 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy
Actual Study Start Date :
Mar 13, 2020
Anticipated Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: VR

The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality

Other: Virtual reality
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.

No Intervention: Printed document

The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.

Outcome Measures

Primary Outcome Measures

  1. Amsterdam Preoperative Anxiety and Information Scale (APAIS) [Prior to receiving the radiotherapy information via VR or printed document]

    Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information - APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)

  2. Amsterdam Preoperative Anxiety and Information Scale (APAIS) [5 minutes after receiving the radiotherapy information via VR or printed document]

    Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information - APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)

Secondary Outcome Measures

  1. State-Trait Anxiety Inventory (STAI) [Prior to receiving the radiotherapy information via VR or printed document]

    Changes in STAI Before and After Providing Virtual Reality or Printed Document Information

  2. State-Trait Anxiety Inventory (STAI) [5 minutes after receiving the radiotherapy information via VR or printed document]

    Changes in STAI Before and After Providing Virtual Reality or Printed Document Information

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Breast cancer patients who received curative surgery and are planned to receive radiotherapy

  2. Patients with cognitive abilities to receive virtual reality information

  3. Patients who are 20 years old or older

Exclusion Criteria:
  1. Patients who have vision or hearing problems to receive information

  2. Patients who do not agree to this study

  3. Pregnancy, Fetuses / Newborns, Minors, and Deficient Patients

  4. 65 years old or older

  5. Patients who have been treated for dizziness within the last 6 months

  6. Patients who have experienced severe dizziness within the last 6 months when using electronic devices

Contacts and Locations

Locations

Site City State Country Postal Code
1 Severance Hospital Seoul Korea Korea, Republic of 120-752

Sponsors and Collaborators

  • Yonsei University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT04141943
Other Study ID Numbers:
  • 4-2019-0795
First Posted:
Oct 28, 2019
Last Update Posted:
Nov 18, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yonsei University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2020